Who
Jennifer Honeycutt
President and CEO
Company insider
Files Form 4 as: President and CEO, Veralto; Executive Vice President, Danaher.
In numbers
- Trades disclosed
- 126
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $15.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 31 Jan 2020
- Last trade
- 23 Oct 2026
- Last filed
- 23 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Oct 2026filed 23 Oct 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Code M | $204K7,098 at $28.76 | filing |
| 23 Oct 2026filed 23 Oct 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Sold | $745K7,098 at $105.00 | filing |
| 23 Oct 2026filed 23 Oct 2026 | VLTO Veraltooption or derivative · Life-science tools | SEC FORM 4 Code M | —7,098 at $0.00 | filing |
| 20 Oct 2026filed 22 Oct 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Code F | $336K3,551 at $94.68 | filing |
| 20 Oct 2026filed 22 Oct 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Code F | $45K474 at $94.68 | filing |
| 29 Jul 2026filed 31 Jul 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Code M | $204K7,097 at $28.76 | filing |
| 29 Jul 2026filed 31 Jul 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Sold | $720K7,097 at $101.52 | filing |
| 29 Jul 2026filed 31 Jul 2026 | VLTO Veraltooption or derivative · Life-science tools | SEC FORM 4 Code M | —7,097 at $0.00 | filing |
| 29 Jul 2026filed 31 Jul 2026 | VLTO Veraltooption or derivative · Life-science tools | SEC FORM 4 Code M | —7,097 at $0.00 | filing |
| 29 Jul 2026filed 31 Jul 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Code M | $204K7,097 at $28.76 | filing |
| 29 Jul 2026filed 31 Jul 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Sold | $720K7,097 at $101.52 | filing |
| 17 Jul 2026filed 21 Jul 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Code M | $204K7,097 at $28.76 | filing |
| 17 Jul 2026filed 21 Jul 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Sold | $674K7,097 at $95.00 | filing |
| 17 Jul 2026filed 21 Jul 2026 | VLTO Veraltooption or derivative · Life-science tools | SEC FORM 4 Code M | —7,097 at $0.00 | filing |
| 17 Jul 2026filed 21 Jul 2026 | VLTO Veraltooption or derivative · Life-science tools | SEC FORM 4 Code M | —7,097 at $0.00 | filing |
| 17 Jul 2026filed 21 Jul 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Code M | $204K7,097 at $28.76 | filing |
| 17 Jul 2026filed 21 Jul 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Sold | $674K7,097 at $95.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | VLTO VeraltoLife-science tools | SEC FORM 4 Code A | —26,943 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | VLTO Veraltooption or derivative · Life-science tools | SEC FORM 4 Code A | —91,273 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | VLTO Veraltooption or derivative · Life-science tools | SEC FORM 4 Code A | —91,273 at $0.00 | filing |
News
Insider Selling: Veralto (NYSE:VLTO) CEO Sells 7,098 Shares of StockVLTO · tickerreport.com · 23 Oct 2026Veralto (NYSE:VLTO) vs. Openlane (NYSE:OPLN) Head-To-Head ComparisonVLTO · themarketsdaily.com · 21 Oct 2026
0 headlines in the last 90 days name Jennifer Honeycutt; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.